Cargando…
Registered report: Discovery and preclinical validation of drug indications using compendia of public gene expression data
The Reproducibility Project: Cancer Biology seeks to address growing concerns about reproducibility in scientific research by conducting replications of 50 papers in the field of cancer biology published between 2010 and 2012. This Registered report describes the proposed replication plan of key exp...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4443697/ https://www.ncbi.nlm.nih.gov/pubmed/25939392 http://dx.doi.org/10.7554/eLife.06847 |
_version_ | 1782373038827765760 |
---|---|
author | Kandela, Irawati Zervantonakis, Ioannis |
author_facet | Kandela, Irawati Zervantonakis, Ioannis |
author_sort | Kandela, Irawati |
collection | PubMed |
description | The Reproducibility Project: Cancer Biology seeks to address growing concerns about reproducibility in scientific research by conducting replications of 50 papers in the field of cancer biology published between 2010 and 2012. This Registered report describes the proposed replication plan of key experiments from ‘Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data’ by Sirota et al., published in Science Translational Medicine in 2011 (Sirota et al., 2011). The key experiments being replicated include Figure 4C and D and Supplemental Figure 1. In these figures, Sirota and colleagues. tested a proof of concept experiment validating their prediction that cimetidine, a histamine-2 (H2) receptor agonist commonly used to treat peptic ulcers (Kubecova et al., 2011), would be effective against lung adenocarcinoma (Figure 4C and D). As a control they also tested the effects of cimetidine against renal carcinoma, for which it was not predicted to be efficacious (Supplemental Figure 1). The Reproducibility Project: Cancer Biology is a collaboration between the Center for Open Science and Science Exchange, and the results of the replications will be published by eLife. DOI: http://dx.doi.org/10.7554/eLife.06847.001 |
format | Online Article Text |
id | pubmed-4443697 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | eLife Sciences Publications, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-44436972015-05-27 Registered report: Discovery and preclinical validation of drug indications using compendia of public gene expression data Kandela, Irawati Zervantonakis, Ioannis eLife Human Biology and Medicine The Reproducibility Project: Cancer Biology seeks to address growing concerns about reproducibility in scientific research by conducting replications of 50 papers in the field of cancer biology published between 2010 and 2012. This Registered report describes the proposed replication plan of key experiments from ‘Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data’ by Sirota et al., published in Science Translational Medicine in 2011 (Sirota et al., 2011). The key experiments being replicated include Figure 4C and D and Supplemental Figure 1. In these figures, Sirota and colleagues. tested a proof of concept experiment validating their prediction that cimetidine, a histamine-2 (H2) receptor agonist commonly used to treat peptic ulcers (Kubecova et al., 2011), would be effective against lung adenocarcinoma (Figure 4C and D). As a control they also tested the effects of cimetidine against renal carcinoma, for which it was not predicted to be efficacious (Supplemental Figure 1). The Reproducibility Project: Cancer Biology is a collaboration between the Center for Open Science and Science Exchange, and the results of the replications will be published by eLife. DOI: http://dx.doi.org/10.7554/eLife.06847.001 eLife Sciences Publications, Ltd 2015-05-05 /pmc/articles/PMC4443697/ /pubmed/25939392 http://dx.doi.org/10.7554/eLife.06847 Text en © 2015, Kandela et al http://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Human Biology and Medicine Kandela, Irawati Zervantonakis, Ioannis Registered report: Discovery and preclinical validation of drug indications using compendia of public gene expression data |
title | Registered report: Discovery and preclinical validation of drug
indications using compendia of public gene expression data |
title_full | Registered report: Discovery and preclinical validation of drug
indications using compendia of public gene expression data |
title_fullStr | Registered report: Discovery and preclinical validation of drug
indications using compendia of public gene expression data |
title_full_unstemmed | Registered report: Discovery and preclinical validation of drug
indications using compendia of public gene expression data |
title_short | Registered report: Discovery and preclinical validation of drug
indications using compendia of public gene expression data |
title_sort | registered report: discovery and preclinical validation of drug
indications using compendia of public gene expression data |
topic | Human Biology and Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4443697/ https://www.ncbi.nlm.nih.gov/pubmed/25939392 http://dx.doi.org/10.7554/eLife.06847 |
work_keys_str_mv | AT kandelairawati registeredreportdiscoveryandpreclinicalvalidationofdrugindicationsusingcompendiaofpublicgeneexpressiondata AT zervantonakisioannis registeredreportdiscoveryandpreclinicalvalidationofdrugindicationsusingcompendiaofpublicgeneexpressiondata AT registeredreportdiscoveryandpreclinicalvalidationofdrugindicationsusingcompendiaofpublicgeneexpressiondata |